Editorial board

Editors:

• Andrea Novelli (Department of Preclinical and Clinical Pharmacology, University of Florence, Italy) [email protected]
• Enrico Mini (Department of Preclinical and Clinical Pharmacology, University of Florence, Italy) [email protected]
• Teresita Mazzei (Department of Preclinical and Clinical Pharmacology, University of Florence, Italy) [email protected]

Antimicrobial Editorial Board:

• Gianfranco Amicosante (Department of Biomedical Sciences and Technologies, University of Aquila, Italy)
• Carlos Bantar (Hospital San Martin, Paranà, Argentina)
• Francesco Barchiesi (Institute of Infectious diseases and Public Medicine, Polytechnic University of Marche, Italy)
• Matteo Bassetti (Infectious Diseases Division, Santa Maria della Misericordia University Hospital, Udine, Italy)
• Elisa Bertazzoni-Minelli (Department Of Medicine and Public Health, University of Verona, Italy)
• Francesco Blasi (Institute of Respiratory Tract Diseases, University of Milan, Italy)
• Joseph M Blondeau (Royal University Hospital, Saskatoon, Canada)
• Tommaso Cai (Department of Urology, Santa Chiara Hospital, Italy)
• Elio Castagnola (Infectious Diseases Unit, G. Gaslini Children's Hospital, Genoa, Italy)
• Sergio Colizza (Chirurgia Generale, FBF, Isola Tiberina, Rome, Italy)
• Burke A Cunha (Infectious Diseases Division, Winthrop-University Hospital, Mineola, NY, USA)
• Christopher A Elkins (Division of Molecular Biology, U.S. Food and Drug Administration, USA)
• Silvano Esposito (Department of Infectious Diseases, University of Salerno, Italy)
• Marco Falcone (Department of Infection Disease, University of Pisa, Italy)
• Vassilios Fanos (Neonatal Pathology, Intensive Care, Cagliari Hospital, Cagliari, Italy)
• Lanfranco Fattorini (Department of Infectious Diseases, Parasitology, Istituto Superiore Sanità, Rome, Italy)
• Alexander A Firsov (Gause Institute of New Antibiotics, Russian Academy of Medical Sciences, Moscow, Russia)
• Thomas R Fritsche (Clinical Microbiology, Marshfield Labs, USA)
• Mahmoud A Ghannoum (Case Western Reserve University, University Hospitals Cleveland, OH, USA)
• Daniele Roberto Giacobbe (University of Genoa, Italy)
• Ian M Gould (Department of Microbiology, Aberdeen Royal Infirmary, UK)
• Po-Ren Hsueh (National Taiwan University Hospital, Taiwan)
• Ronald N Jones (JMI Laboratories, North Creek, IA, USA)
• Vladimir Krcmery (Department of Clinical Pharmacology, Rector, St. Elizabeth University of Health and Social Sciences, Bratislava, Slovakia)
• Luca Lazzarini (Infectious Diseases Unit, St. Bortolo Hospital, Vicenza, Italy)
• Ronald C Li (Clinical Pharmacology, Roche, Palo Alto, CA, USA)
• Alasdair MacGowan (Medical Microbiology, Southmead Hospital, Bristol, UK)
• Anna Marchese (Institute of Microbiology, University of Genoa, Italy)
• Ziad A Memish (Assistant Deputy Minister of Preventive Medicine, Ministry of Health, Riyadh, Saudi Arabia)
• Francesco Menichetti (Infectious Diseases Unit, Cisanello Hospital, Pisa, Italy)
• Giulia Morace (Department of Public Health, University of Milan, Italy)
• Kurt Naber (former Professor of Urology, Technical University of Munich, Germany)
• Salvatore Oliveri (Department of Microbiology, University of Catania, Italy)
• Livio Pagano (Institute Of Hematology, Catholic University of the Sacred Heart, Rome, Italy)
• Georgios Pappas (Institute of Continuing Medical Education, Ioannina, Greece)
• David L Paterson (University of Queensland Centre for Clinical Research, Australia)
• Thomas F Patterson (University Of Texas Health Science Center, San Antonio, TX, USA)
• George L Petrikkos (Attikon University Hospital, Athens, Greece)
• Johann D D Pitout (University of Calgary, Canada)
• Kristian Riesbeck (Department of Medical Microbiology, Lund University, Sweden)
• Luigina Romani (Department of Experimental Medicine and Biochemistry, University of Perugia, Perugia, Italy)
• Francesco Rossi (Department of Experimental Medicine, University of Naples, Italy)
• Gian Maria Rossolini (Department of Molecular Biology, University of Siena, Italy)
• Caroline Sabin (Royal Free, University College Medical School, London, UK)
• Helio S Sader (JMI Laboratories, USA)
• Maurizio Sanguinetti (Institute of Microbiology, Catholic University of the Sacred Heart, Rome, Italy)
• Francesco Scaglione (Department of Pharmacology, University of Milan, Italy)
• Atef Shibl (King Saud University, Riyadh, Saudi Arabia)
• Leung Kei (Kris) Siu (Division of Clinical Research, National Health Research Institutes, Taiwan)
• Stefania Stefani (Department of Microbiology, University of Catania, Italy)
• Gloria Taliani (Department of Infectious Tropical Diseases, Sapienza University of Rome, Italy)
• Carlo Tascini (Azienda Ospedaliero-Universitaria Pisana-AOUP, Pisa, Italy)
• Annamaria Tortorano (Department of Public Health, Microbiology, University of Milan, Italy)
• Athanassios Tsakris (Department of Microbiology, University of Athens, Greece)
• Mario Venditti (Department of Internal Medicine, Policlinico Umberto I, University of Rome, Italy)
• Pierluigi Viale (Department of Infectious Diseases, University, Policlinico S. Orsola Malpighi, Italy)
• Nao-aki Watanabe (Tsukuba Research Laboratories, Eisai Col, Tsukuba, Japan)

Anticancer Editorial Board:

• Debabrata Banerjee (Rutgers Cancer Institute of New Jersey, New Brunswick, USA)
• Guido Bocci (Department of Clinical and Experimental Medicine, School of Medicine, University of Pisa, Italy)
• Alberto Bosi (Department of Hematology, University of Florence Hospital, Italy)
• Stergios Boussios (Faculty of Life Sciences and Medicine, School of Cancer and Pharmaceutical Sciences, King's College London, London, UK)
• Etienne Chatelut (Institut Claudius-Regaud, Toulouse, France)
• Giuseppe Curigliano (Department of Experimental Oncology, European Institute of Oncology IRCCS, 20139 Milan, Italy 2. Department of Oncology and Hemato-Oncology, University of Milano, 20140 Milan, Italy)
• Romano Danesi (Department of Chemotherapy and Pharmacology, University of Pisa, Italy)
• Antonello Di Paolo (Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy)
  
• Raffaella Giavazzi (Laboratory of Biology and Treatment of Metastasis, IRCCS-Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy)
• Antonio Giordano (Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, Department of Biology, Temple University, Philadelphia, USA)
• Elisa Giovanetti (Amsterdam UMC, VU University Medical Center, Laboratory Medical Oncology, Cancer Center Amsterdam, Amsterdam, Netherlands)
• Georg Hempel (Department of Pharmaceutical and Medical Chemistry, Clinical Pharmacy, University of Muenster, Muenster, Germany)
• Bashir A Lwaleed (Department of Urology, University of Southampton, Southampton, UK)
• Luciano Martelotto (Development Laboratory, ACE; South Australian Immunogenomics Cancer Institute; Faculty of Health and Medical Sciences, Adelaide University, Canada)
• Stefania Nobili (Department of Health Sciences, University of Florence, Italy)
• José M. Padrón (BioLab, Instituto Universitario de Bio-Orgánica Antonio González (IUBO-AG), Universidad de La Laguna, Spain)
• Godefridus J Peters (Medical Oncology Research Lab, VU University, Netherlands)
• Jean Louis Pujol (Thoracic Oncology Unit, Institute Montepellier Academic Hospital, France)
• Carlo Riccardi (Department of Clinical Medicine, Pathology and Pharmacology, University of Perugia, Italy)
• Jacques Robert (University of Bordeaux, Bordeaux, France)
• Rafael Rosell (Catalan Institute of Oncology, Hospital Germans Trias i Pujol, Spain)
• Gianni Sava (Department of Life Sciences, University of Trieste, Italy)
• Giovanni Scambia (Department of Women's, Children's and Public Health Sciences, Catholic University of the Sacred Heart, Rome, Italy)
• Giuseppe Toffoli (CRO National Cancer Institute, Aviano, Italy)
• Eric Van Cutsem (Digestive Oncology Department, University Hospitals Leuven and KU Leuven, Belgium)
• Paul Workman (Cancer Therapeutics Unit, Cancer Research UK, London, UK)
• Nadia Zaffaroni (Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy)